Interplay between Fanconi anemia and homologous recombination pathways in genome integrity

EMBO Journal

Volumn 35, Issue 9, 2016, Pages 909-923

  Michl, Johanna ^a   Zimmer, Jutta ^a   Tarsounas, Madalena ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

DNA damage response; DNA repair; Fanconi anemia; genome stability; homologous recombination; replication stress

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; FANCI PROTEIN; FANCJ PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; UNCLASSIFIED DRUG; DNA LIGASE; FANCONI ANEMIA PROTEIN;

BONE MARROW CELL; BREAST TUMOR; CANCER SUSCEPTIBILITY; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; DNA REPAIR; DNA REPLICATION; FANCONI ANEMIA; GENE FREQUENCY; GENE MUTATION; GENOMIC INSTABILITY; GERMLINE MUTATION; HETEROZYGOSITY LOSS; HOMOLOGOUS RECOMBINATION; HUMAN; MOLECULAR INTERACTION; NONHUMAN; OVARY TUMOR; PRIORITY JOURNAL; REVIEW; TELOMERE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; NEOPLASM;

DNA REPAIR; DNA REPAIR ENZYMES; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HOMOLOGOUS RECOMBINATION; HUMANS; METABOLIC NETWORKS AND PATHWAYS; NEOPLASMS;

EID: 84963657302     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.15252/embj.201693860     Document Type: Review

References (148)

1. Akbari MR, Tonin P, Foulkes WD, Ghadirian P, Tischkowitz M, Narod SA, (2010) RAD51C germline mutations in breast and ovarian cancer patients. Breast Cancer Res 12: 404
2. Alter BP, (1996) Fanconi's anemia and malignancies. Am J Hematol 53: 99-110
3. Alter BP, (2006) The association between FANCD1/BRCA2 mutations and leukaemia. Br J Haematol 133: 446-448
4. Alter BP, Giri N, Savage SA, Rosenberg PS, (2015) Telomere length in inherited bone marrow failure syndromes. Haematologica 100: 49-54
5. Ameziane N, May P, Haitjema A, van de Vrugt HJ, van Rossum-Fikkert SE, Ristic D, Williams GJ, Balk J, Rockx D, Li H, Rooimans MA, Oostra AB, Velleuer E, Dietrich R, Bleijerveld OB, Maarten Altelaar AF, Meijers-Heijboer H, Joenje H, Glusman G, Roach J, et al, (2015) A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51. Nat Commun 6: 8829
6. Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83: 1301-1308
7. Apostolou S, Whitmore SA, Crawford J, Lennon G, Sutherland GR, Callen DF, lanzano L, Savino M, D'Apolito M, Notarangeio A, Memeo E, Piemontese MR, Zelante L, Savoia A, Gibson RA, Tipping AJ, Morgan NV, Hassock S, Jansen S, de Ravel TJ, et al, (1996) Positional cloning of the Fanconi anaemia group A gene. Nat Genet 14: 324-328
8. Auerbach AD, Buchwald M, Joenje H, (2001) Fanconi Anemia. In Metabolic and Molecular Bases of Inherited Disease, Scriver C, Beaudet AL, Sly WS, Valle D, Vogelstein B, Childs B, (eds), pp 753-768. New York: McGraw-Hill Medical
9. Auerbach AD, Rogatko A, Schroeder-Kurth TM, (1989) International Fanconi anemia registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood 73: 391-396
10. Auerbach AD, Wolman SR, (1976) Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature 261: 494-496
11. Aze A, Zhou JC, Costa A, Costanzo V, (2013) DNA replication and homologous recombination factors: acting together to maintain genome stability. Chromosoma 122: 401-413
12. Badie S, Escandell JM, Bouwman P, Carlos AR, Thanasoula M, Gallardo MM, Suram A, Jaco I, Benitez J, Herbig U, Blasco MA, Jonkers J, Tarsounas M, (2010) BRCA2 acts as a RAD51 loader to facilitate telomere replication and capping. Nat Struct Mol Biol 17: 1461-1469
13. Berwick M, Satagopan JM, Ben-Porat L, Carlson A, Mah K, Henry R, Diotti R, Milton K, Pujara K, Landers T, Dev Batish S, Morales J, Schindler D, Hanenberg H, Hromas R, Levran O, Auerbach AD, (2007) Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer. Cancer Res 67: 9591-9596
14. Bhatia V, Barroso SI, Garcia-Rubio ML, Tumini E, Herrera-Moyano E, Aguilera A, (2014) BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2. Nature 511: 362-365
15. Bogliolo M, Schuster B, Stoepker C, Derkunt B, Su Y, Raams A, Trujillo Juan P, Minguillón J, Ramírez María J, Pujol R, Casado José A, Baños R, Rio P, Knies K, Zúñiga S, Benítez J, Bueren Juan A, Jaspers Nicolaas GJ, Schärer Orlando D, de Winter Johan P, et al, (2013) Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am J Hum Genet 92: 800-806
16. Bouwman P, Jonkers J, (2012) The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance. Nat Rev Cancer 12: 587-598
17. Budzowska M, Graham TG, Sobeck A, Waga S, Walter JC, (2015) Regulation of the Rev1-pol zeta complex during bypass of a DNA interstrand cross-link. EMBO J 34: 1971-1985
18. Bunting SF, Callen E, Kozak ML, Kim JM, Wong N, Lopez-Contreras AJ, Ludwig T, Baer R, Faryabi RB, Malhowski A, Chen HT, Fernandez-Capetillo O, D'Andrea A, Nussenzweig A, (2012) BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair. Mol Cell 46: 125-135
19. Cantor SB, Bell DW, Ganesan S, Kass EM, Drapkin R, Grossman S, Wahrer DC, Sgroi DC, Lane WS, Haber DA, Livingston DM, (2001) BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105: 149-160
20. Castella M, Jacquemont C, Thompson EL, Yeo JE, Cheung RS, Huang J-W, Sobeck A, Hendrickson EA, Taniguchi T, (2015) FANCI regulates recruitment of the FA core complex at sites of DNA damage independently of FANCD2. PLoS Genet 11: e1005563
21. Castillo Bosch P, Segura-Bayona S, Koole W, van Heteren JT, Dewar JM, Tijsterman M, Knipscheer P, (2014) FANCJ promotes DNA synthesis through G-quadruplex structures. EMBO J 33: 2521-2533
22. Chan KL, Palmai-Pallag T, Ying S, Hickson ID, (2009) Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. Nat Cell Biol 11: 753-760
23. Chaudhury I, Sareen A, Raghunandan M, Sobeck A, (2013) FANCD2 regulates BLM complex functions independently of FANCI to promote replication fork recovery. Nucleic Acids Res 41: 6444-6459
24. Chen X, Bosques L, Sung P, Kupfer GM, (2015a) A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage. Oncogene 35: 22-34
25. Chen X, Wilson JB, McChesney P, Williams SA, Kwon Y, Longerich S, Marriott AS, Sung P, Jones NJ, Kupfer GM, (2014) The Fanconi anemia proteins FANCD2 and FANCJ interact and regulate each other's chromatin localization. J Biol Chem 289: 25774-25782
26. Chen YH, Jones MJ, Yin Y, Crist SB, Colnaghi L, Sims RJ 3rd, Rothenberg E, Jallepalli PV, Huang TT, (2015b) ATR-mediated phosphorylation of FANCI regulates dormant origin firing in response to replication stress. Mol Cell 58: 323-338
27. Cheung I, Schertzer M, Rose A, Lansdorp PM, (2002) Disruption of dog-1 in Caenorhabditis elegans triggers deletions upstream of guanine-rich DNA. Nat Genet 31: 405-409
28. Ciccia A, Ling C, Coulthard R, Yan ZJ, Xue YT, Meetei AR, Laghmani EH, Joenje H, McDonald N, de Winter JP, Wang WD, West SC, (2007) Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol Cell 25: 331-343
29. Collis SJ, Ciccia A, Deans AJ, Horejsi Z, Martin JS, Maslen SL, Skehel JM, Elledge SJ, West SC, Boulton SJ, (2008) FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex. Mol Cell 32: 313-324
30. Domchek SM, Tang J, Stopfer J, Lilli DR, Hamel N, Tischkowitz M, Monteiro AN, Messick TE, Powers J, Yonker A, Couch FJ, Goldgar DE, Davidson HR, Nathanson KL, Foulkes WD, Greenberg RA, (2013) Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer. Cancer Discov 3: 399-405
31. Dorsman JC, Levitus M, Rockx D, Rooimans MA, Oostra AB, Haitjema A, Bakker ST, Steltenpool J, Schuler D, Mohan S, Schindler D, Arwert F, Pals G, Mathew CG, Waisfisz Q, de Winter JP, Joenje H, (2007) Identification of the Fanconi anemia complementation group I gene, FANCI. Cell Oncol 29: 211-218
32. Evers B, Jonkers J, (2006) Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects. Oncogene 25: 5885-5897
33. Fan Q, Zhang F, Barrett B, Ren K, Andreassen PR, (2009) A role for monoubiquitinated FANCD2 at telomeres in ALT cells. Nucleic Acids Res 37: 1740-1754
34. Franco S, van de Vrugt HJ, Fernandez P, Aracil M, Arwert F, Blasco MA, (2004) Telomere dynamics in Fancg-deficient mouse and human cells. Blood 104: 3927-3935
35. Friedman LS, Thistlethwaite FC, Patel KJ, Yu VP, Lee H, Venkitaraman AR, Abel KJ, Carlton MB, Hunter SM, Colledge WH, Evans MJ, Ponder BA, (1998) Thymic lymphomas in mice with a truncating mutation in Brca2. Cancer Res 58: 1338-1343
36. Fu YV, Yardimci H, Long DT, Ho TV, Guainazzi A, Bermudez VP, Hurwitz J, van Oijen A, Scharer OD, Walter JC, (2011) Selective bypass of a lagging strand roadblock by the eukaryotic replicative DNA helicase. Cell 146: 931-941
37. Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J, Grompe M, D'Andrea AD, (2001) Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 7: 249-262
38. García-Rubio ML, Pérez-Calero C, Barroso SI, Tumini E, Herrera-Moyano E, Rosado IV, Aguilera A, (2015) The Fanconi anemia pathway protects genome integrity from R-loops. PLoS Genet 11: e1005674
39. Gari K, Decaillet C, Delannoy M, Wu L, Constantinou A, (2008) Remodeling of DNA replication structures by the branch point translocase FANCM. Proc Natl Acad Sci USA 105: 16107-16112
40. Gaymes TJ, Shall S, Farzaneh F, Mufti GJ, (2008) Chromosomal instability syndromes are sensitive to poly ADP-ribose polymerase inhibitors. Haematologica 93: 1886-1889
41. Gibbs-Seymour I, Oka Y, Rajendra E, Weinert BT, Passmore LA, Patel KJ, Olsen JV, Choudhary C, Bekker-Jensen S, Mailand N, (2015) Ubiquitin-SUMO circuitry controls activated fanconi anemia ID complex dosage in response to DNA damage. Mol Cell 57: 150-164
42. Godthelp BC, Wiegant WW, van Duijn-Goedhart A, Schärer OD, van Buul PPW, Kanaar R, Zdzienicka MZ, (2002) Mammalian Rad51C contributes to DNA cross-link resistance, sister chromatid cohesion and genomic stability. Nucleic Acids Res 30: 2172-2182
43. Gong Z, Kim JE, Leung CC, Glover JN, Chen J, (2010) BACH1/FANCJ acts with TopBP1 and participates early in DNA replication checkpoint control. Mol Cell 37: 438-446
44. Gupta R, Sharma S, Sommers JA, Kenny MK, Cantor SB, Brosh RM Jr, (2007) FANCJ (BACH1) helicase forms DNA damage inducible foci with replication protein A and interacts physically and functionally with the single-stranded DNA-binding protein. Blood 110: 2390-2398
45. Hashimoto Y, Puddu F, Costanzo V, (2012) RAD51- and MRE11-dependent reassembly of uncoupled CMG helicase complex at collapsed replication forks. Nat Struct Mol Biol 19: 17-24
46. Hatchi E, Skourti-Stathaki K, Ventz S, Pinello L, Yen A, Kamieniarz-Gdula K, Dimitrov S, Pathania S, McKinney Kristine M, Eaton Matthew L, Kellis M, Hill Sarah J, Parmigiani G, Proudfoot Nicholas J, Livingston David M, (2015) BRCA1 recruitment to transcriptional pause sites is required for R-loop-driven DNA damage repair. Mol Cell 57: 636-647
47. Hira A, Yoshida K, Sato K, Okuno Y, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Shimamoto A, Tahara H, Ito E, Kojima S, Kurumizaka H, Ogawa S, Takata M, Yabe H, Yabe M, (2015) Mutations in the gene encoding the E2 conjugating enzyme UBE2T cause Fanconi anemia. Am J Hum Genet 96: 1001-1007
48. Howlett NG, Taniguchi T, Durkin SG, D'Andrea AD, Glover TW, (2005) The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum Mol Genet 14: 693-701
49. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, Persky N, Grompe M, Joenje H, Pals G, Ikeda H, Fox EA, D'Andrea AD, (2002) Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297: 606-609
50. Huang M, Kim JM, Shiotani B, Yang K, Zou L, D'Andrea AD, (2010) The FANCM/FAAP24 complex is required for the DNA interstrand crosslink-induced checkpoint response. Mol Cell 39: 259-268
51. Hussain S, Wilson JB, Medhurst AL, Hejna J, Witt E, Ananth S, Davies A, Masson JY, Moses R, West SC, de Winter JP, Ashworth A, Jones NJ, Mathew CG, (2004) Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum Mol Genet 13: 1241-1248
52. Ilves I, Petojevic T, Pesavento JJ, Botchan MR, (2010) Activation of the MCM2-7 helicase by association with Cdc45 and GINS proteins. Mol Cell 37: 247-258
53. Jackson SP, Durocher D, (2013) Regulation of DNA damage responses by ubiquitin and SUMO. Mol Cell 49: 795-807
54. Jensen RB, Ozes A, Kim T, Estep A, Kowalczykowski SC, (2013) BRCA2 is epistatic to the RAD51 paralogs in response to DNA damage. DNA Repair 12: 306-311
55. Joenje H, Patel KJ, (2001) The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet 2: 446-459
56. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A, (2001) Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29: 418-425
57. Kalb R, Duerr M, Wagner M, Herterich S, Gross M, Digweed M, Joenje H, Hoehn H, Schindler D, (2004) Lack of sensitivity of primary Fanconi's anemia fibroblasts to UV and ionizing radiation. Radiat Res 161: 318-325
58. Kashiyama K, Nakazawa Y, Pilz DT, Guo C, Shimada M, Sasaki K, Fawcett H, Wing JF, Lewin SO, Carr L, Li T-S, Yoshiura K, Utani A, Hirano A, Yamashita S, Greenblatt D, Nardo T, Stefanini M, McGibbon D, Sarkany R, et al, (2013) Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes cockayne syndrome, Xeroderma pigmentosum, and Fanconi anemia. Am J Hum Genet 92: 807-819
59. Kee Y, D'Andrea AD, (2010) Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev 24: 1680-1694
60. Kiiski JI, Pelttari LM, Khan S, Freysteinsdottir ES, Reynisdottir I, Hart SN, Shimelis H, Vilske S, Kallioniemi A, Schleutker J, Leminen A, Bützow R, Blomqvist C, Barkardottir RB, Couch FJ, Aittomäki K, Nevanlinna H, (2014) Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer. Proc Natl Acad Sci USA 111: 15172-15177
61. Kim H, D'Andrea AD, (2012) Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes Dev 26: 1393-1408
62. Kim Y, Lach FP, Desetty R, Hanenberg H, Auerbach AD, Smogorzewska A, (2011) Mutations of the SLX4 gene in Fanconi anemia. Nat Genet 43: 142-146
63. Kim Y, Spitz GS, Veturi U, Lach FP, Auerbach AD, Smogorzewska A, (2013) Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4. Blood 121: 54-63
64. King M-C, Marks J, Mandell J, (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302: 643-646
65. Klein Douwel D, Boonen RA, Long DT, Szypowska AA, Raschle M, Walter JC, Knipscheer P, (2014) XPF-ERCC1 acts in Unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP/SLX4. Mol Cell 54: 460-471
66. Kottemann MC, Smogorzewska A, (2013) Fanconi anaemia and the repair of Watson and Crick DNA crosslinks. Nature 493: 356-363
67. Kruisselbrink E, Guryev V, Brouwer K, Pontier DB, Cuppen E, Tijsterman M, (2008) Mutagenic capacity of endogenous G4 DNA underlies genome instability in FANCJ-defective C. elegans. Curr Biol 18: 900-905
68. Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF, Hanenberg H, Auerbach AD, (2003) A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101: 1249-1256
69. Langevin F, Crossan GP, Rosado IV, Arends MJ, Patel KJ, (2011) Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice. Nature 475: 53-58
70. Levitus M, Waisfisz Q, Godthelp BC, de Vries Y, Hussain S, Wiegant WW, Elghalbzouri-Maghrani E, Steltenpool J, Rooimans MA, Pals G, Arwert F, Mathew CG, Zdzienicka MZ, Hiom K, De Winter JP, Joenje H, (2005) The DNA helicase BRIP1 is defective in Fanconi anemia complementation group. J Nat Genet 37: 934-935
71. Levran O, Attwooll C, Henry RT, Milton KL, Neveling K, Rio P, Batish SD, Kalb R, Velleuer E, Barral S, Ott J, Petrini J, Schindler D, Hanenberg H, Auerbach AD, (2005) The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet 37: 931-933
72. Litman R, Peng M, Jin Z, Zhang F, Zhang J, Powell S, Andreassen PR, Cantor SB, (2005) BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 8: 255-265
73. Lomonosov M, Anand S, Sangrithi M, Davies R, Venkitaraman AR, (2003) Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein. Genes Dev 17: 3017-3022
74. London TB, Barber LJ, Mosedale G, Kelly GP, Balasubramanian S, Hickson ID, Boulton SJ, Hiom K, (2008) FANCJ is a structure-specific DNA helicase associated with the maintenance of genomic G/C tracts. J Biol Chem 283: 36132-36139
75. Long DT, Joukov V, Budzowska M, Walter JC, (2014) BRCA1 promotes unloading of the CMG helicase from a stalled DNA replication fork. Mol Cell 56: 174-185
76. Long DT, Raschle M, Joukov V, Walter JC, (2011) Mechanism of RAD51-dependent DNA interstrand cross-link repair. Science 333: 84-87
77. Lossaint G, Larroque M, Ribeyre C, Bec N, Larroque C, Decaillet C, Gari K, Constantinou A, (2013) FANCD2 binds MCM proteins and controls replisome function upon activation of s phase checkpoint signaling. Mol Cell 51: 678-690
78. Luke-Glaser S, Luke B, Grossi S, Constantinou A, (2010) FANCM regulates DNA chain elongation and is stabilized by S-phase checkpoint signalling. EMBO J 29: 795-805
79. Machida YJ, Machida Y, Chen Y, Gurtan AM, Kupfer GM, D'Andrea AD, Dutta A, (2006) UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol Cell 23: 589-596
80. Matsuzaki K, Borel V, Adelman CA, Schindler D, Boulton SJ, (2015) FANCJ suppresses microsatellite instability and lymphomagenesis independent of the Fanconi anemia pathway. Genes Dev 29: 2532-2546
81. Meetei AR, de Winter JP, Medhurst AL, Wallisch M, Waisfisz Q, van de Vrugt HJ, Oostra AB, Yan Z, Ling C, Bishop CE, Hoatlin ME, Joenje H, Wang W, (2003) A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet 35: 165-170
82. Meetei AR, Levitus M, Xue Y, Medhurst AL, Zwaan M, Ling C, Rooimans MA, Bier P, Hoatlin M, Pals G, de Winter JP, Wang W, Joenje H, (2004) X-linked inheritance of Fanconi anemia complementation group B. Nat Genet 36: 1219-1224
83. Meetei AR, Medhurst AL, Ling C, Xue Y, Singh TR, Bier P, Steltenpool J, Stone S, Dokal I, Mathew CG, Hoatlin M, Joenje H, de Winter JP, Wang W, (2005) A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet 37: 958-963
84. Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, Freund M, Lichtner P, Hartmann L, Schaal H, Ramser J, Honisch E, Kubisch C, Wichmann HE, Kast K, Deissler H, Engel C, Muller-Myhsok B, Neveling K, Kiechle M, et al, (2010) Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 42: 410-414
85. Mimitou EP, Symington LS, (2011) DNA end resection-unraveling the tail. DNA Repair 10: 344-348
86. Mosedale G, Niedzwiedz W, Alpi A, Perrina F, Pereira-Leal JB, Johnson M, Langevin F, Pace P, Patel KJ, (2005) The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Nat Struct Mol Biol 12: 763-771
87. Moynahan ME, Pierce AJ, Jasin M, (2001) BRCA2 is required for homology-directed repair of chromosomal breaks. Mol Cell 7: 263-272
88. Naim V, Rosselli F, (2009) The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities. Nat Cell Biol 11: 761-768
89. Nakanishi K, Taniguchi T, Ranganathan V, New HV, Moreau LA, Stotsky M, Mathew CG, Kastan MB, Weaver DT, D'Andrea AD, (2002) Interaction of FANCD2 and NBS1 in the DNA damage response. Nat Cell Biol 4: 913-920
90. Nakanishi K, Yang YG, Pierce AJ, Taniguchi T, Digweed M, D'Andrea AD, Wang ZQ, Jasin M, (2005) Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc Natl Acad Sci USA 102: 1110-1115
91. Navarro S, Meza NW, Quintana-Bustamante O, Casado JA, Jacome A, McAllister K, Puerto S, Surralles J, Segovia JC, Bueren JA, (2006) Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1. Mol Ther 14: 525-535
92. Nimonkar AV, Genschel J, Kinoshita E, Polaczek P, Campbell JL, Wyman C, Modrich P, Kowalczykowski SC, (2011) BLM-DNA2-RPA-MRN and EXO1-BLM-RPA-MRN constitute two DNA end resection machineries for human DNA break repair. Genes Dev 25: 350-362
93. Ohashi A, Zdzienicka MZ, Chen J, Couch FJ, (2005) Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage. J Biol Chem 280: 14877-14883
94. Orthwein A, Noordermeer SM, Wilson MD, Landry S, Enchev RI, Sherker A, Munro M, Pinder J, Salsman J, Dellaire G, Xia B, Peter M, Durocher D, (2015) A mechanism for the suppression of homologous recombination in G1 cells. Nature 528: 422-426
95. Patel KJ, Yu VP, Lee H, Corcoran A, Thistlethwaite FC, Evans MJ, Colledge WH, Friedman LS, Ponder BA, Venkitaraman AR, (1998) Involvement of Brca2 in DNA repair. Mol Cell 1: 347-357
96. Peterlongo P, Catucci I, Colombo M, Caleca L, Mucaki E, Bogliolo M, Marin M, Damiola F, Bernard L, Pensotti V, Volorio S, Dall'Olio V, Meindl A, Bartram C, Sutter C, Surowy H, Sornin V, Dondon MG, Eon-Marchais S, Stoppa-Lyonnet D, et al, (2015) FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor. Hum Mol Genet 24: 5345-5355
97. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR, (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91: 943-949
98. Pontel LB, Rosado IV, Burgos-Barragan G, Garaycoechea JI, Yu R, Arends MJ, Chandrasekaran G, Broecker V, Wei W, Liu L, Swenberg JA, Crossan GP, Patel KJ, (2015) Endogenous formaldehyde is a hematopoietic stem cell genotoxin and metabolic carcinogen. Mol Cell 60: 177-188
99. Powell SN, Xia F, Zhang J, Feng Z, (2002) Breast cancer cells with deficiencies in BRCA1/BRCA2 show hypersensitivity to mitomycin C. Int J Radiat Oncol 54: 52
100. Rafnar T, Gudbjartsson DF, Sulem P, Jonasdottir A, Sigurdsson A, Besenbacher S, Lundin P, Stacey SN, Gudmundsson J, Magnusson OT, le Roux L, Orlygsdottir G, Helgadottir HT, Johannsdottir H, Gylfason A, Tryggvadottir L, Jonasson JG, de Juan A, Ortega E, Ramon-Cajal JM, et al, (2011) Mutations in BRIP1 confer high risk of ovarian cancer. Nat Genet 43: 1104-1107
101. Rajendra E, Oestergaard Vibe H, Langevin F, Wang M, Dornan Gillian L, Patel Ketan J, Passmore Lori A, (2014) The genetic and biochemical basis of FANCD2 monoubiquitination. Mol Cell 54: 858-869
102. Raschle M, Smeenk G, Hansen RK, Temu T, Oka Y, Hein MY, Nagaraj N, Long DT, Walter JC, Hofmann K, Storchova Z, Cox J, Bekker-Jensen S, Mailand N, Mann M, (2015) DNA repair. Proteomics reveals dynamic assembly of repair complexes during bypass of DNA cross-links. Science 348: 1253671
103. Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M, Wurm M, Batish SD, Lach FP, Yetgin S, Neitzel H, Ariffin H, Tischkowitz M, Mathew CG, Auerbach AD, Rahman N, (2007) Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 39: 162-164
104. Reuter M, Zelensky A, Smal I, Meijering E, van Cappellen WA, de Gruiter HM, van Belle GJ, van Royen ME, Houtsmuller AB, Essers J, Kanaar R, Wyman C, (2015) BRCA2 diffuses as oligomeric clusters with RAD51 and changes mobility after DNA damage in live cells. J Cell Biol 207: 599-613
105. Rhee DB, Wang Y, Mizesko M, Zhou F, Haneline L, Liu Y, (2010) FANCC suppresses short telomere-initiated telomere sister chromatid exchange. Hum Mol Genet 19: 879-887
106. Rickman KA, Lach FP, Abhyankar A, Donovan FX, Sanborn EM, Kennedy JA, Sougnez C, Gabriel SB, Elemento O, Chandrasekharappa SC, Schindler D, Auerbach AD, Smogorzewska A, (2015) Deficiency of UBE2T, the E2 ubiquitin ligase necessary for FANCD2 and FANCI ubiquitination, causes FA-T subtype of Fanconi anemia. Cell Rep 12: 35-41
107. Rottenberg S, Nygren AOH, Pajic M, van Leeuwen FWB, van der Heijden I, van de Wetering K, Liu X, de Visser KE, Gilhuijs KG, van Tellingen O, Schouten JP, Jonkers J, Borst P, (2007) Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer. Proc Natl Acad Sci USA 104: 12117-12122
108. Roy R, Chun J, Powell SN, (2012) BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer 12: 68-78
109. Rutter JL, Smith AM, Davila MR, Sigurdson AJ, Giusti RM, Pineda MA, Doody MM, Tucker MA, Greene MH, Zhang J, Struewing JP, (2003) Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals. Hum Mutat 22: 121-128
110. Sakai W, Swisher EM, Karlan BY, Agarwal MK, Higgins J, Friedman C, Villegas E, Jacquemont C, Farrugia DJ, Couch FJ, Urban N, Taniguchi T, (2008) Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers. Nature 451: 1116-1120
111. Sarkies P, Murat P, Phillips LG, Patel KJ, Balasubramanian S, Sale JE, (2012) FANCJ coordinates two pathways that maintain epigenetic stability at G-quadruplex DNA. Nucleic Acids Res 40: 1485-1498
112. Sawyer SL, Tian L, Kahkonen M, Schwartzentruber J, Kircher M, Majewski J, Dyment DA, Innes AM, Boycott KM, Moreau LA, Moilanen JS, Greenberg RA, (2015) Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. Cancer Discov 5: 135-142
113. Schlacher K, Christ N, Siaud N, Egashira A, Wu H, Jasin M, (2011) Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11. Cell 145: 529-542
114. Schlacher K, Wu H, Jasin M, (2012) A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. Cancer Cell 22: 106-116
115. Schwab RA, Blackford AN, Niedzwiedz W, (2010) ATR activation and replication fork restart are defective in FANCM-deficient cells. EMBO J 29: 806-818
116. Schuster B, Knies K, Stoepker C, Velleuer E, Friedl R, Gottwald-Mühlhauser B, de Winter JP, Schindler D, (2013) Whole exome sequencing reveals uncommon mutations in the recently identified Fanconi anemia gene SLX4/FANCP. Hum Mutat 34: 93-96
117. Schwab RA, Nieminuszczy J, Shah F, Langton J, Lopez Martinez D, Liang C-C, Cohn Martin A, Gibbons Richard J, Deans Andrew J, Niedzwiedz W, (2015) The Fanconi anemia pathway maintains genome stability by coordinating replication and transcription. Mol Cell 60: 351-361
118. Schwab RA, Nieminuszczy J, Shin-ya K, Niedzwiedz W, (2013) FANCJ couples replication past natural fork barriers with maintenance of chromatin structure. J Cell Biol 201: 33-48
119. Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, Chagtai T, Jayatilake H, Ahmed M, Spanova K, North B, McGuffog L, Evans DG, Eccles D, Easton DF, Stratton MR, Rahman N, (2006) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38: 1239-1241
120. Sims AE, Spiteri E, Sims RJ 3rd, Arita AG, Lach FP, Landers T, Wurm M, Freund M, Neveling K, Hanenberg H, Auerbach AD, Huang TT, (2007) FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nat Struct Mol Biol 14: 564-567
121. Sirbu BM, McDonald WH, Dungrawala H, Badu-Nkansah A, Kavanaugh GM, Chen Y, Tabb DL, Cortez D, (2013) Identification of proteins at active, stalled, and collapsed replication forks using isolation of proteins on nascent DNA (iPOND) coupled with mass spectrometry. J Biol Chem 288: 31458-31467
122. Skoulidis F, Cassidy LD, Pisupati V, Jonasson JG, Bjarnason H, Eyfjord JE, Karreth FA, Lim M, Barber LM, Clatworthy SA, Davies SE, Olive KP, Tuveson DA, Venkitaraman AR, (2010) Germline Brca2 heterozygosity promotes KrasG12D-driven carcinogenesis in a murine model of familial pancreatic cancer. Cancer Cell 18: 499-509
123. Smogorzewska A, Matsuoka S, Vinciguerra P, McDonald ER 3rd, Hurov KE, Luo J, Ballif BA, Gygi SP, Hofmann K, D'Andrea AD, Elledge SJ, (2007) Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129: 289-301
124. Strathdee CA, Gavish H, Shannon WR, Buchwald M, (1992) Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 356: 763-767
125. Stoepker C, Hain K, Schuster B, Hilhorst-Hofstee Y, Rooimans MA, Steltenpool J, Oostra AB, Eirich K, Korthof ET, Nieuwint AW, Jaspers NG, Bettecken T, Joenje H, Schindler D, Rouse J, de Winter JP, (2011) SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype. Nat Genet 43: 138-141
126. Suwaki N, Klare K, Tarsounas M, (2011) RAD51 paralogs: roles in DNA damage signalling, recombinational repair and tumorigenesis. Semin Cell Dev Biol 22: 898-905
127. Tacconi EM, Tarsounas M, (2015) How homologous recombination maintains telomere integrity. Chromosoma 124: 119-130
128. Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory RC, Grompe M, Andrea AD, (2002) S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100: 2414-2420
129. Timmers C, Taniguchi T, Hejna J, Reifsteck C, Lucas L, Bruun D, Thayer M, Cox B, Olson S, D'Andrea AD, Moses R, Grompe M, (2001) Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell 7: 241-248
130. Tsang E, Carr AM, (2008) Replication fork arrest, recombination and the maintenance of ribosomal DNA stability. DNA Repair (Amst) 7: 1613-1623
131. Vaz F, Hanenberg H, Schuster B, Barker K, Wiek C, Erven V, Neveling K, Endt D, Kesterton I, Autore F, Fraternali F, Freund M, Hartmann L, Grimwade D, Roberts RG, Schaal H, Mohammed S, Rahman N, Schindler D, Mathew CG, (2010) Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet 42: 406-409
132. Venkitaraman AR, (2009) Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu Rev Pathol 4: 461-487
133. Virts EL, Jankowska A, Mackay C, Glaas MF, Wiek C, Kelich SL, Lottmann N, Kennedy FM, Marchal C, Lehnert E, Scharf RE, Dufour C, Lanciotti M, Farruggia P, Santoro A, Savasan S, Scheckenbach K, Schipper J, Wagenmann M, Lewis T, et al, (2015) AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia. Hum Mol Genet 24: 5093-5108
134. Wagner JE, Tolar J, Levran O, Scholl T, Deffenbaugh A, Satagopan J, Ben-Porat L, Mah K, Batish SD, Kutler DI, MacMillan ML, Hanenberg H, Auerbach AD, (2004) Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. Blood 103: 3226-3229
135. Wang X, Andreassen PR, D'Andrea AD, (2004) Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol Cell Biol 24: 5850-5862
136. Wang AT, Kim T, Wagner JE, Conti BA, Lach FP, Huang AL, Molina H, Sanborn EM, Zierhut H, Cornes BK, Abhyankar A, Sougnez C, Gabriel SB, Auerbach AD, Kowalczykowski SC, Smogorzewska A, (2015) A dominant mutation in human RAD51 reveals its function in DNA interstrand crosslink repair independent of homologous recombination. Mol Cell 59: 478-490
137. Wang AT, Smogorzewska A, (2015) SnapShot: Fanconi anemia and associated proteins. Cell 160: 354-354.e1
138. de Winter JP, Rooimans MA, van Der Weel L, van Berkel CG, Alon N, Bosnoyan-Collins L, de Groot J, Zhi Y, Waisfisz Q, Pronk JC, Arwert F, Mathew CG, Scheper RJ, Hoatlin ME, Buchwald M, Joenje H, (2000) The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat Genet 24: 15-16
139. Wu Y, Shin-ya K, Brosh RM Jr, (2008) FANCJ helicase defective in Fanconia anemia and breast cancer unwinds G-quadruplex DNA to defend genomic stability. Mol Cell Biol 28: 4116-4128
140. Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, Sheng Q, Pals G, Errami A, Gluckman E, Llera J, Wang W, Livingston DM, Joenje H, de Winter JP, (2006a) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39: 159-161
141. Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu J, Christ N, Liu X, Jasin M, Couch FJ, Livingston DM, (2006b) Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell 22: 719-729
142. Xu X, Wagner K-U, Larson D, Weaver Z, Li C, Ried T, Hennighausen L, Wynshaw-Boris A, Deng C-X, (1999) Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22: 37-43
143. Youds JL, Barber LJ, Ward JD, Collis SJ, O'Neil NJ, Boulton SJ, Rose AM, (2007) DOG-1 is the Caenorhabditis elegans BRIP1/FANCJ homologue and functions in interstrand cross-link repair. Mol Cell Biol 28: 1470-1479
144. Zeman MK, Cimprich KA, (2014) Causes and consequences of replication stress. Nat Cell Biol 16: 2-9
145. Zhang F, Fan Q, Ren K, Auerbach AD, Andreassen PR, (2010) FANCJ/BRIP1 recruitment and regulation of FANCD2 in DNA damage responses. Chromosoma 119: 637-649
146. Zhang J, Walter JC, (2014) Mechanism and regulation of incisions during DNA interstrand cross-link repair. DNA Repair 19: 135-142
147. Zheng Y, Zhang J, Hope K, Niu Q, Huo D, Olopade O, (2010) Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer. Breast Cancer Res Treat 124: 857-861
148. Zimmer J, Tacconi EM, Folio C, Badie S, Porru M, Klare K, Tumiati M, Markkanen E, Halder S, Ryan A, Jackson SP, Ramadan K, Kuznetsov SG, Biroccio A, Sale JE, Tarsounas M, (2016) Targeting BRCA1 and BRCA2 deficiencies with G-quadruplex-interacting compounds. Mol Cell 61: 449-460